France’s Sanofi eyes rising earnings in 2022 after Q4 earnings increase By Reuters
© Reuters. FILE PHOTO: A woman, wearing a protective face mask, walks past the logo of Sanofi at the company’s headquarters in Paris, France, January 31, 2022. REUTERS/Violeta Santos Moura
PARIS (Reuters) – French drugmaker Sanofi (NASDAQ:) said it would aim to further increase its earnings per share (EPS) this year as it reported rising fourth-quarter results on Friday.
The group, which is hoping for a comeback after losing ground in the COVID-19 jab race, is eyeing an increase in its EPS in the “low double-digit” in 2022.
Its sales in the three months to December grew 4.1% to 9.99 billion euros ($11.45 billion) while its EPS came in at 1.38 euros.
For the whole of 2021, its earnings per share rose by 15.5% at constant exchange rates, while the company had guided for a rise of 14%.
($1 = 0.8725 euros)
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.